España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Indaptus Therapeutics
INDP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.9380
0.05
5.39%
At close: -
$0.9620
0.02
2.56%
After Hours: Dec 20, 9:13 AM EDT
Get Report
Comment
Indaptus Therapeutics (INDP) Forecast
News
Earnings
Indaptus Therapeutics (INDP) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Indaptus Therapeutics (NASDAQ:INDP) Stock
Indaptus Therapeutics Stock (NASDAQ: INDP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 22, 2024
Indaptus Therapeutics shares are trading lowe...
Benzinga Newsdesk
Indaptus Therapeutics Announces $2.135M Regis...
Benzinga Newsdesk
Wednesday, November 13, 2024
Maxim Group Maintains Buy on Indaptus Therape...
Benzinga Newsdesk
Tuesday, November 12, 2024
Indaptus Therapeutics Q3 2024 GAAP EPS $(0.32...
Benzinga Newsdesk
Monday, November 11, 2024
Indaptus Therapeutics' Pioneering Research On...
Benzinga Newsdesk
Friday, November 08, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, November 07, 2024
Indaptus Therapeutics Presents Encouraging In...
Benzinga Newsdesk
Tuesday, October 22, 2024
Indaptus Therapeutics Announces Clinical Supp...
Benzinga Newsdesk
Wednesday, October 16, 2024
Indaptus Therapeutics shares are trading high...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk
Tuesday, October 15, 2024
Indaptus Therapeutics shares are trading high...
Benzinga Newsdesk
Indaptus Therapeutics Initiates Unrestricted ...
Benzinga Newsdesk
Friday, September 27, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Thursday, September 05, 2024
Indaptus Therapeutics Reports New Safety Data...
Benzinga Newsdesk
Monday, August 12, 2024
Indaptus Therapeutics Q2 EPS $(0.47) Beats $(...
Benzinga Newsdesk
Wednesday, August 07, 2024
Indaptus Therapeutics Entered Into Securities...
Benzinga Newsdesk
Monday, June 17, 2024
HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk
Tuesday, June 11, 2024
Indaptus Therapeutics To Present At STING & T...
Benzinga Newsdesk
Friday, June 07, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Tuesday, June 04, 2024
Indaptus Therapeutics To Present New Positive...
Benzinga Newsdesk
Monday, June 03, 2024
Indaptus Therapeutics Announces New Data From...
Benzinga Newsdesk
Wednesday, May 29, 2024
Indaptus Therapeutics Presents New Cohort Dat...
Benzinga Newsdesk
Wednesday, May 22, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Indaptus Therapeutics shares are trading high...
Benzinga Newsdesk
Indaptus Therapeutics First Patient Received ...
Benzinga Newsdesk
Wednesday, May 08, 2024
Indaptus Therapeutics Q1 EPS $(0.45) Misses $...
Benzinga Newsdesk
Thursday, May 02, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, May 01, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, April 15, 2024
HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk
Thursday, April 11, 2024
Indaptus Therapeutics Unveils Details On Mech...
Benzinga Newsdesk
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, March 25, 2024
Indaptus Therapeutics Previews Mechanism Of A...
Benzinga Newsdesk
Wednesday, March 13, 2024
Indaptus Therapeutics: Q4 Earnings Insights
Benzinga Insights
Indaptus Therapeutics FY EPS $(1.83) Beats $(...
Benzinga Newsdesk
Monday, March 11, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Monday, March 04, 2024
Indaptus Therapeutics Announces Results From ...
Benzinga Newsdesk
Thursday, February 29, 2024
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, February 08, 2024
Indaptus Therapeutics Launches Social Media C...
Benzinga Newsdesk
Thursday, January 04, 2024
European Patent Office Approves Patent For In...
Benzinga Newsdesk
Monday, November 06, 2023
Indaptus Therapeutics Q3 EPS $(0.47) Beats $(...
Benzinga Newsdesk
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Indaptus Therapeutics shares are trading high...
Benzinga Newsdesk
Indaptus Therapeutics Announces Interim Data ...
Benzinga Newsdesk
Tuesday, October 31, 2023
Indaptus Therapeutics To Present Pharmacodyna...
Benzinga Newsdesk
Wednesday, September 20, 2023
HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk
Tuesday, September 19, 2023
Indaptus Therapeutics Doses First Patient In ...
Benzinga Newsdesk
Thursday, August 17, 2023
Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Lisa Levin
Tuesday, August 15, 2023
HC Wainwright & Co. Reiterates Buy on Indaptu...
Benzinga Newsdesk
Monday, August 14, 2023
Indaptus Therapeutics Q2 EPS $(0.39) Beats $(0.58) Estimate
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch